ReviewVaccines2023

New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review.

Arvind Nune et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.